ACE2 and COVID-19: In the pandemic context of COVID-19, current smokers have an increased risk of presenting the worst outcomes [8]; in the airway, a higher expression of angiotensin-converting enzyme 2 (ACE2) [3] in smokers has been found, which is the receptor through the virus is internalized to the cells [9].